MISSION
” We contribute to the development of the regenerative medicine industry by sharing Japan’s advanced cell processing technology with the world. “
The history of regenerative medicine in Japan is one of the oldest in the world, and technological innovation has always been advanced.
There are many countries, especially developing countries, where regenerative medicine has not taken root.
Including the training of local cell processing technicians/specialists, we provide guidance on cell processing protocols so that advanced cell processing can be performed stably in countries around the world.
PROCESS
① Selection of cell processing protocol
We will mainly transfer the following cell processing technology.
Protocols of autologous (own stem cells and blood) are below.
● Stem cell protocol (adipose tissue, bone marrow tissue)
● Stem cell culture supernatant protocol
● Creation of exosome isolation
● PRP/PRP-FD
Protocols of others (other people’s stem cells and blood) are below.
● Stem cell protocol (Umbilical cord, Wharton jelly, amniotic fluid, placental villi)
● Stem cell culture supernatant protocol
● Exosome isolation and creation (research reagents, cosmetic materials)
● PRP/PRP-FD
② Determining the method of technology transfer
We will consider the technology transfer method depending on the customer’s personnel structure and the content of the technology transfer.
③ Start of technology transfer
We will support you to start stable cell processing.